lipogenesis is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-09-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Lyophilized peptide; protect from moisture and light. |
| Typical analytical method | HPLC and mass spectrometry | Used to confirm identity and estimate purity. |
| Common synonyms | AOD9604; hGH 176-191 | Naming varies by supplier and publication. |
| Disulfide bonds | One | Affects folded structure and stability. |
| Typical research purity | ≥95% | Value depends on supplier and analytical method. |
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
=== Disadvantages === The primary focus of the iTDP approach is the comprehensiveness of analyses and thus data quality, rather than high throughput. Many claim this as a drawback of the approach. With the widespread adoption of BUP since the turn of the century, a much-touted goal of proteomics has been to achieve high-throughput analyses of amino acid sequences, comparable to the throughput of genomic analyses. Critically, this seems (quantitatively) unlikely considering the vast potential speciation of protein products and thus the complexity of native proteomes. A truly disruptive (as yet unidentified) technology would be required to genuinely enable quantitatively comprehensive, high-throughput proteome analyses. 2DE has been described as time-consuming or labour-intensive. Again, the issue is clearly one of analytical quality over speed. While it is true that iTDP — notably performed with full, parallel technical replicates — can take longer than a single BUP or MSi-TDP run (i.e. without parallel technical replicates), when one factors in the inherent technical aspects of those approaches (e.g. LC column optimization and packing, multiple orthogonal LC runs, effective system flushing, cleaning clogged electrospray systems, data handling/analysis), there is not a substantial difference in throughput. Furthermore, recent refinements have further optimized sample handling and increased 2DE throughput. It is difficult to ensure full, quantitative recovery of intact proteoforms from polyacrylamide gels, and this varies with the size of species and the PTM present.
=== Threats to other countries === Trump set his sights on a number of countries in the following days. Trump signaled an eagerness to apply pressure on Colombia and said when asked that a similar operation there "sounds good to me". Trump threatened Colombia's president Gustavo Petro, saying he has "cocaine mills and cocaine factories" and "likes making cocaine and selling it to the United States" but would not be doing it much longer. Trump had recently sanctioned the Colombian leader for his alleged reluctance to combat drug trafficking in the country. Petro promised to take up arms if he had to, and Colombia's Ministry of Foreign Affairs issued a statement opposing "an undue interference" in domestic politics. Days later Trump and Petro agreed in a phone call to work together on combating drug trafficking and domestic insurgency, with Petro demanding that Trump "strike hard" against the ELN in both Venezuela and Colombia; Petro said fighting the ELN "in the rear" was just as critical as attacking it inside Colombia. Trump threatened Mexico and Cuba, saying the two nations needed to do more to earn US favor, but said the latter might "fall" without US interference; he also expressed hope that Mexico would act on its own. In an appearance on Hannity Trump said that "We are going to start now hitting land with regard to the cartels. The cartels are running Mexico". Newsweek noted that Trump had said land strikes were imminent before, but also that he had been doing the groundwork by designating cartels Foreign Terrorist Organizations.
October 23, denoted 10/23 in the US, is recognized by some as Mole Day. It is an informal holiday in honor of the unit among chemists. The date is derived from the Avogadro number, which is approximately 6.022×1023. It starts at 6:02 a.m. and ends at 6:02 p.m. Alternatively, some chemists celebrate June 2 (06/02), June 22 (6/22), or 6 February (06.02), a reference to the 6.02 or 6.022 part of the constant.
==== Other androgenic and antiandrogenic actions ==== A paradoxical effect occurs with certain prostate cancer cells which have genetic mutations in their ARs. These altered ARs can be activated, rather than inhibited, by CPA. In such cases, withdrawal of CPA may result in a reduction in cancer growth, rather than the reverse. This is known as antiandrogen withdrawal syndrome. CPA may also have a slight direct inhibitory effect on 5α-reductase, though the evidence for this is sparse and conflicting. Most studies however suggest that CPA does not produce important inhibition of 5α-reductase. The combination of birth control pills containing CPA with finasteride, a well-established, selective 5α-reductase inhibitor, has been found to result in significantly improved effectiveness in the treatment of hirsutism relative to CPA-containing birth control pills alone. In addition to its AR antagonistic activity and suppression of gonadal sex-hormone production, high-dose CPA has been found to suppress the levels of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S), which is due to exertion of negative feedback by CPA on adrenocorticotropic hormone (ACTH) secretion via the glucocorticoid activity of CPA.
Sources: en.wikipedia.org
The researcher found that, in this case, reverse phase HPLC, was a better, more sensitive technique despite the time savings in direct injection. Analysis of pharmaceuticals by MLC is also gaining popularity. The selectivity and peak shape of MLC over commonly used ion-pair chromatography is much enhanced. MLC mimics, yet enhances, the selectivity offered by ion-pairing reagents for the separation of active ingredients in pharmaceutical drugs. For basic drugs, MLC improves the excessive peak tailing frequently observed in ion-pairing. Hydrophilic drugs are often unretained using conventional HPLC, are retained by MLC due to solubilization into the micelles. Commonly found drugs in cold medications such as acetaminophen, L-ascorbic acid, phenylpropanolamine HCL, tipepidine hibenzate, and chlorpheniramine maleate have been successfully separated with good peak shape using MLC. Additional basic drugs like many narcotics, such as codeine and morphine, have also been successfully separated using MLC. Another novel application of MLC involves the separation and analysis of inorganic compounds, mostly simple ions. This is a relatively new area for MLC, but has seen some promising results. MLC has been observed to provide better selectivity of inorganic ions that ion-exchange or ion-pairing chromatography. While this application is still in the beginning stages of development, the possibilities exist for novel, much enhanced separations of inorganic species. Since the technique was first reported on in 1980, micellar liquid chromatography has been used in hundreds of applications.
== D == dalton – Darwinian fitness – Darwinism – decomposer – dehydrogenase – deletion – denaturation – dendrite – dengue – denitrification – deoxyribonucleic acid – deoxyribose – depolarization – desmosome – deuterostome – diabetes mellitus – diastole – diffusion – digestion – dihybrid cross – dikaryon – dikaryotic – disaccharide – DNA ligase – DNA methylation – DNA polymerase – double circulation – double helix – Down syndrome – drupe – duodenum – dynein
== Contraindications == The drug is contraindicated in subjects with known hypersensitivity to the active ingredient or to any of the inactive ingredients contained in the pharmaceutical formulation. It is also contraindicated in women who are pregnant and breastfeeding.
=== Spectrum of bacterial resistance and susceptibility === Cefadroxil has a broad spectrum of activity and has been effective in treating bacteria responsible for causing tonsillitis, and infections of the skin and urinary tract. Cefadroxil covers similar organisms to cephalexin given that it is a derivative drug. The following represents MIC susceptibility data for a few medically significant microorganisms.
==== Japan ==== In Japan, the terms "cidre" (シードル, shīdoru) or "apple sparkling wine" usually refer to the alcoholic beverage to distinguish it from the sparkling unalcoholic soda drink, cider, although both terms are now interchangeably used. While Japan is not historically a cider-making country, there is currently a renaissance of new, younger cider makers in the prefectures of Aomori and Nagano, such as Aomori's A-Factory. In 2019, the number of international ciders imported to Japan increased, signifying a start to its popularity among Japanese consumers.
Sources: en.wikipedia.org
=== Real-time cell-binding === In this type of assay the binding of a ligand to cells is followed over time. The obtained signal is proportional to the number of ligands bound to a target structure, often a receptor, on the cell surface. Information about the ligand-target interaction is obtained from the signal change over time and kinetic parameters such as the association rate constant ka, the dissociation rate constant kd and the affinity KD can be calculated. By measuring the interaction directly on cells, no isolation of the target protein is needed, which can otherwise be challenging, especially for some membrane proteins. To ensure that the interaction with the intended target structure is measured appropriate biological controls, such as cells not expressing the target structure, are recommended. Real-time measurements using label-free or label-based approaches have been used to analyze biomolecular interactions on fixated or on living cells. The advantage of measuring ligand-receptor interactions in real-time, is that binding equilibrium does not need to be reached for accurate determination of the affinity.
===== Fat-soluble vitamins ===== Vitamin A is required in kitten diets because cats cannot convert carotenes to retinol in the intestinal mucosa due to a lack of the necessary enzyme; therefore, this vitamin must be supplied in the diet. Vitamin E is another required vitamin in kitten diets; deficiency leads to steatitis, causing the depot fat to become firm and yellow-orange in colour, which is painful and leads to death. Also, vitamin D is essential because cats cannot convert it from precursors in the skin.
A variety of serotonergic psychedelics have been assessed and found to produce neurotoxicity at high concentrations in vitro and/or high doses in vivo in rodents. These psychedelics have included DOI, 2C-B, 25B-NBOMe, 25C-NBOMe, 5-MeO-DiPT, 5-MeO-MiPT, methallylescaline (MAL), and BOD, among others. The neurotoxicity induced by the preceding psychedelics has included MDMA-like serotonergic neurotoxicity, for instance with DOI, MAL, and 5-MeO-DiPT. The neurotoxicity of psychedelics has been found to be partially blocked by serotonin 5-HT2A receptor inhibition, which was also the case with the neurotoxicity of MDMA. Besides producing neurotoxicity on their own, psychedelics have been found to potentiate the serotonergic neurotoxicity of MDMA via serotonin 5-HT2 receptor activation in rodents. DOM is known to metabolize into 2,5-DDM-DOM (2-O-,5-O-didesmethyl-DOM; 2,5-dihydroxy-4-methylamphetamine), which bears a close resemblance to 6-hydroxydopamine (6-OHDA; 2,4,5-trihydroxyphenethylamine) and has been found to be a potent neurotoxin similarly. Other related phenethylamine psychedelics may also undergo similar metabolism and form analogous potentially neurotoxic metabolites. Chronic administration of LSD has been associated with long-lasting schizophrenia-like behavioral changes in rodents, which was not blocked by serotonin 5-HT2A receptor antagonism but may instead be related to LSD's dopamine D2-like receptor agonism.
== Honours and achievements == Essendon captain: 2010–2016 2× All-Australian team: 2012, 2013 3× Crichton Medal: 2009, 2010, 2012 AFLPA best captain award: 2012 Australia representative honours in international rules football: 2014 Yiooken Award: 2013
Sources: en.wikipedia.org
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.
The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.
It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.